Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypertension.

S Oparil1, D A Calhoun

  • 1Hypertension Research Program, University of Alabama, Birmingham School of Medicine.

Disease-A-Month : DM
|March 1, 1989
PubMed
Summary
This summary is machine-generated.

High blood pressure (hypertension) affects millions, necessitating efficient management. Lifestyle changes and targeted medications are key to controlling blood pressure and reducing cardiovascular risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intensive Blood Pressure Management Preserves Functional Connectivity in Patients with Hypertension from the Systolic Blood Pressure Intervention Randomized Trial.

AJNR. American journal of neuroradiology·2023
Same author

Lowering Albuminuria-Does It Lower the Cardiovascular Risk?: Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 45: 198-202, 2005.

Journal of the American Society of Nephrology : JASN·2023
Same author

Reducing Microalbuminuria-Does It Lower Cardiovascular Risk?: Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 45: 198-202, 2005.

Journal of the American Society of Nephrology : JASN·2023
Same author

Blood Pressure Measurement Challenges in Severely Obese Patients.

American journal of hypertension·2018
Same author

Maternal and neonatal demographics of macrosomic infants admitted to the neonatal intensive care unit.

Journal of perinatology : official journal of the California Perinatal Association·2017
Same author

Sleep disorders and hypertension risk.

Journal of human hypertension·2017
Same journal

Disturbances due to cold.

Disease-a-month : DM·2026
Same journal

GLP-1 agonist and neuroprotection in Stroke and Parkinson's disease: A systematic review.

Disease-a-month : DM·2026
Same journal

GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review.

Disease-a-month : DM·2026
Same journal

Periodontal disease and diabetic kidney disease: A comprehensive analysis.

Disease-a-month : DM·2026
Same journal

Foreword for Glucagon-like peptide-1 receptor agonists (GLP-1) and its promise for potential benefits.

Disease-a-month : DM·2026
Same journal

Foreword for insulin autoimmune syndrome (Hirata Disease): An updated review of epidemiology, pathophysiology, clinical features, diagnosis, and management.

Disease-a-month : DM·2026
See all related articles

Area of Science:

  • Cardiovascular Medicine
  • Hypertension Research

Background:

  • High blood pressure (hypertension) affects an estimated 58 million Americans, increasing risk for morbidity and premature death.
  • Effective diagnosis and management strategies are crucial for this prevalent disorder.

Purpose of the Study:

  • To review recent advances in understanding hypertension pathogenesis.
  • To explore new diagnostic and treatment approaches for secondary hypertension.
  • To present current views on managing essential hypertension with nonpharmacologic and pharmacologic therapies.

Main Methods:

  • Review of recent evidence on nonpharmacologic antihypertensive therapy.
  • Analysis of pharmacologic treatment options for essential hypertension.
  • Emphasis on cost-effective strategies for diagnosis and management.

Related Experiment Videos

Main Results:

  • Nonpharmacologic therapies (dietary changes, weight loss, exercise, smoking cessation, moderation of alcohol) significantly reduce blood pressure and cardiovascular risk.
  • Nonpharmacologic approaches can manage mild hypertension or reduce medication needs in severe cases.
  • Individualized pharmacologic therapy using agents like diuretics, ACE inhibitors, calcium channel blockers, and beta-blockers is effective for many patients.

Conclusions:

  • Nonpharmacologic antihypertensive therapy should be part of all hypertension treatment plans.
  • Personalized pharmacologic treatment, considering pathophysiology and drug side effects, is essential for optimal blood pressure control.
  • Combining nonpharmacologic and pharmacologic strategies ensures effective and safe hypertension management.